News

Annovis Bio's Participation in Key Neuroscience Conference

Annovis Bio's Participation in Key Neuroscience Conference

Annovis Bio to Participate in Renowned Neuroscience Event

MALVERN, Pa. — Annovis Bio Inc. (NYSE: ANVS), a prominent clinical-stage biopharmaceutical company focused on pioneering innovative therapies for neurodegenerative diseases, is thrilled to announce its participation in the upcoming AD/PD™ 2025 conference.

Highlights from the Conference

This prestigious event, set to take place in Vienna from April 1-5, will see Annovis showcasing vital research findings related to Alzheimer's disease (AD) and Parkinson's disease (PD), two conditions that greatly impact millions worldwide. During the conference, Annovis will present data from its latest clinical studies, which underscore the potential of its lead product, buntanetap, in effectively treating these conditions.

Presentations on Groundbreaking Research

The company has scheduled two significant presentations and a forum discussion at the conference:

First Presentation: Buntanetap Improves Early Parkinson's Patients' Cognition and Motor Functions in a Phase 3 Study
Date: April 1
Time: 2:45 – 3:00 PM CET
Presenter: Maria Maccecchini, Ph.D., Founder and CEO

Second Presentation: APOE4 and Buntanetap in Phase II/III Alzheimer’s Patients
Date: April 2
Time: 9:40 – 9:55 AM CET
Presenter: Cheng Fang, Ph.D., SVP, Research and Development

Additionally, Annovis will participate in a forum discussion titled Novel Approaches to Accelerate Development of Biomarkers, Imaging, and Therapy of Alpha-Synuclein, LRRK2, and GBA Pathologies Linked to PD, LBD, and MSA on April 4 from 4:20 to 5:20 PM CET, featuring discussion led by Dr. Maccecchini.

Significance of the AD/PD™ Conference

The AD/PD™ conference is a crucial platform that brings together leading experts from around the world to discuss recent advancements in the fields of Alzheimer's and Parkinson's research. This year's conference will highlight the latest breakthroughs in drug development, early diagnosis techniques, and translational research, allowing researchers and clinicians to engage with pivotal ideas and collaborations that may shape the future of treatment in neurodegenerative diseases.

About Annovis Bio

Based in Malvern, Pennsylvania, Annovis is on a mission to tackle the challenges of neurodegeneration in diseases such as Alzheimer's and Parkinson's. The company is committed to innovating therapies that aim to enhance not just the clinical outcomes for patients but also their quality of life.

Staying Informed

Interested individuals can learn more by visiting Annovis's website, where updates and more information regarding their innovative approaches and ongoing trials can be found.

Contact Details for Inquiries

For further inquiries, reach out to:
Annovis Bio Inc.
101 Lindenwood Drive
Suite 225
Malvern, PA 19355
Website: www.annovisbio.com

Investor Communications

Investors and shareholders are encouraged to register for email alerts on press releases and industry updates, ensuring they remain informed on developments within the company and the field.

Frequently Asked Questions

What is Annovis Bio focused on?

Annovis Bio concentrates on developing innovative therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's diseases.

When will Annovis present at the conference?

Annovis will hold its first presentation on April 1 and a second on April 2 at the AD/PD 2025 conference.

Who are the presenters from Annovis Bio?

Maria Maccecchini, Ph.D., and Cheng Fang, Ph.D., will be giving the key presentations during the conference.

Where is the conference being held?

The AD/PD 2025 conference is set to take place in Vienna.

How can I stay updated with Annovis Bio news?

Visit the company's website and register for email alerts to stay informed about ongoing research and company news.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Scientel Solutions Connects North Central Athletes on Road

Updated Category News Views 1

Boosting Connectivity for Student-Athletes Here's a nugget that slips under the radar unless you're looking with both eyes open: Scientel Solutions, from Aurora, Illinois, is shaking up the connectivity game for North Central College's athletic department. These folks have realized something many don't quite grasp—keeping student-athletes connected is no luxury; it's...

Continue Reading
Catholic Colleges Excel in AI Readiness, Study Shows

Updated Category News Views 1

Faith and Tech: An Unexpected Alliance? Alright, here's something that'll make you sit up: Catholic college grads are not just busy sipping their morning coffee while they muse over moral philosophy—they're out there on the front lines of artificial intelligence, better prepared and more engaged than their peers from secular schools. According to the latest Holistic...

Continue Reading
Baystate Noble Plans Major ED Expansion for Future Needs

Updated Category News Views 2

A Trusted Name in Healthcare Steps Up When a healthcare player like Baystate Health decides to jump into the deep end with an expansion project, you know they're not just doodling on napkins. With a legacy stretching back to 1883, Baystate Health, anchored deeply in western New England, isn't just expanding for fun—it's a move to cement its position as a crucial...

Continue Reading
Empirik.ai's $21M for AI in Infrastructure Revolution

Updated Category News Views 12

AI-Powered Infrastructure Takes the Stage Well, here's a tech gambit going full steam: empirik.ai just hit the digital scene with a $21 million war chest. Fresh out of the stealth shadows, they've got big names like Sequoia Capital, S32, Canapi Ventures, and Alumni Ventures stamping their ticket. What's the fuss? They're rolling out the first AI agent designed to...

Continue Reading
Taiwan's Machine Emerges as Heavy-Tonnage Game Changer

Updated Category News Views 1

Every once in a while, the machinery scene gets rocked by something that genuinely raises eyebrows, and it seems Chuan Lih Fa Machinery Works Co., Ltd. (CLF) has just delivered one of those moments. This isn't just any old injection molding machine—it's Taiwan's very first 5000-ton giant, crafted with robust precision and dispatched straight to a major U.S. logistics...

Continue Reading
G20's Bold Move: Main Street Meets Wall Street

Updated Category News Views 3

An Unexpected Invitation to the Elite Table You'd think a community bank from Oklahoma crashing a party of international finance heavyweights sounds odd, but that's exactly how the G20 threw down this year. Holding the reins, the U.S. took a swing at something different. Secretary of the Treasury Scott Bessent rolled out the red carpet for private-sector leaders,...

Continue Reading
Finzly Launches AI Security Layer Amid Rising Threats

Updated Category News Views 3

Bank Security in the Age of AI You'd think banks, of all places, were impenetrable fortresses. But these days, they're more like digital targets. With AI-driven attacks becoming as common as morning coffee, Finzly's introducing Assure, an AI-powered security and assurance layer. It's about as timely as ever, given the 89% spike in AI-enabled attacks seen last year. When...

Continue Reading
Miracle Cocktails Unveils Global Expansion for 2026

Updated Category News Views 5

Reimaging Spirits: Miracle's 12th Season is Here Holiday-themed cocktail pop-ups? That's Miracle Cocktails Inc. for you, making a splash since 2014 and showing no signs of slowing. This year, they're rolling out over 150 locations across the globe, sparking joy like a kid in a candy store. These aren't just bar crawls; they're full-blown holiday experiences that tickle...

Continue Reading
Flotek Faces Lawsuit: Investors Urged to Act Fast

Updated Category News Views 3

Flotek's Current Storm: Gather Your Wits, Shareholders If you've staked your hard-earned cash into Flotek Industries, Inc. (FTK), it's high time to buckle up. Those court-blaring sirens aren’t a drill: we're talking class-action territory, people. The Law Offices of Howard G. Smith sound the alarm, calling on investors who’ve had their financial feathers singed to...

Continue Reading
MD Integrations' Bold Cert Link: Telehealth's New Era

Updated Category News Views 3

MD Integrations Paves a New Path in Telehealth Well, folks, it seems someone’s finally listening. MD Integrations is taking a serious swing at solving one of telehealth's big hiccups – compliance delays. By roping in LegitScript directly, they’re all set to smooth the rocky road to launching virtual care brands. The Sticky Issue of Compliance Delays Anyone dabbling...

Continue Reading

Top 5 Most Recently Viewed Articles

Class Action Lawsuit Filed Against The Aaron's Company Inc.

Updated Category News Views 363

Class Action Lawsuit Announced Against The Aaron's Company Inc. Ademi & Fruchter LLP has taken a significant step by filing a class action lawsuit against The Aaron's Company Inc. This action is being pursued on behalf of individuals and entities that have held securities in The Aaron's Company Inc. (NYSE: AAN). The lawsuit has been registered in the United States...

Continue Reading
Block's Tidal Faces Major Workforce Reductions Under CEO Dorsey

Updated Category News Views 189

Block's Restructuring Plans for Tidal Jack Dorsey, the CEO of Block Inc. (NYSE: SQ), has recently unveiled plans for significant layoffs at Tidal, the music streaming service owned by Block. His announcement has stirred considerable attention in the entertainment and tech sectors alike. Details on the Layoffs On a recent communication with Tidal employees, Dorsey...

Continue Reading
Symphony Unveils Innovative Biodegradable Resin Solution

Updated Category News Views 282

Symphony Introduces NbR: A Game-Changer in Sustainability Symphony Environmental Technologies Plc has unveiled NbR, a groundbreaking biodegradable resin designed to address the need for eco-friendly materials. This innovative product is intended for use in packaging and agricultural films, reflecting the company's dedication to sustainable solutions in the plastic...

Continue Reading
Moroccan Markets Experience Gains as Key Sectors Rally

Updated Category News Views 323

Moroccan Markets Experience Gains as Key Sectors Rally In recent trading, Morocco's stock market has shown notable resilience, largely supported by positive movements in various sectors. The Moroccan All Shares index closed with a gain of 0.25%, highlighting the strength of the equity markets. Performance of Key Sectors The uplifting results in the Moroccan stock market...

Continue Reading
Dana Simonds Joins HealthTrackRx as Chief Compliance Officer

Updated Category News Views 383

HealthTrackRx Announces Dana Simonds as Chief Compliance Officer HealthTrackRx, a leader in molecular diagnostic testing, welcomes Dana Simonds, CHC, CHPC, as their new Chief Compliance Officer. Simonds is known for her extensive experience in compliance and regulatory strategy within the healthcare sector. Her appointment signifies HealthTrackRx's commitment to...

Continue Reading